CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
bluebird bio Inc Company Snapshot
bluebird bio Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares bluebird bio Inc with three other companies in this sector in the United States: Portola Pharmaceuticals Inc (2015 sales of $12.07 million ), Blueprint Medicines Corp ($11.40 million of which 100% was Biopharmaceutical), and Concert Pharmaceuticals Inc ($16.57 million ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
bluebird bio Inc
  Stock Performance Chart for bluebird bio Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 77.10
(Figures in U.S. Dollars)
1 Week 1.8%   13 Weeks 17.9%  
4 Weeks 24.4%   52 Weeks 48.1%  
 
bluebird bio Inc Key Data:
  Ticker: BLUE Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 14,079,000
(Year Ending Jan 2016).
Employees: 254
  Currency: U.S. Dollars Market Cap: 3,129,109,360
  Fiscal Yr Ends: December Shares Outstanding: 40,585,076
  Share Type: Common Closely Held Shares: 376,665
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.